# Antineoplaston Therapy in Treating Children With Brain Tumors

> **NCT00003458** · PHASE2 · COMPLETED · sponsor: **Burzynski Research Institute** · enrollment: 34 (actual)

## Conditions studied

- Childhood Brain Tumors

## Interventions

- **DRUG:** Antineoplaston therapy (Atengenal + Astugenal)

## Key facts

- **NCT ID:** NCT00003458
- **Lead sponsor:** Burzynski Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003458, "Antineoplaston Therapy in Treating Children With Brain Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*